Moritz has a M.Sc. in Biochemistry and focuses primarily on the biochemistry of proteins, as well as their functional and structural analysis. For his bachelor’s thesis, he synthesized peptides linked to nanoparticles that specifically target and kill cancer cells. During his master’s degree, he expanded his focus further to immunology, conducting structure-function investigations of the tapasin-MHC class I interaction; these are two important proteins involved in presenting antigens to the immune system. Subsequently, he worked at Charité, investigating the role of WT1 (Wilms tumor protein) activity in adipocytes, with the goal of further elucidating its function in determining white adipocytes, which could lead to new applications for combating obesity.
Moritz is currently a Ph.D. candidate and part of the FIP („Forschungsimpulse“) project at the Berlin University of Applied Sciences and Technology (BHT). His research focuses on quantitatively characterizing the physical properties of the cytoplasm. This includes monitoring changes in mass density, macromolecule distribution, and viscoelastic properties. He is also part of the IMPRS-IDI (International Max Planck Research School for Infectious Diseases and Immunology), conducting his experiments at the Max Planck Institute for Infection Biology.